Effect of dietary fat content in meals on pharmacokinetics of quazepam

Journal of Clinical Pharmacology

Volumn 42, Issue 12, 2002, Pages 1335-1340

  Yasui Furukori, Norio ^a   Kondo, Tsuyoshi ^a   Takahata, Takenori ^a   Mihara, Kazuo ^a   Ono, Shingo ^a   Kaneko, Sunao ^a   Tateishi, Tomonori ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 5 (2 FLUOROPHENYL) 1,3 DIHYDRO 1 (2,2,2 TRIFLUOROETHYL) 2H 1,4 BENZODIAZEPIN 2 ONE; HYPNOTIC SEDATIVE AGENT; QUAZEPAM;

ADULT; APPLE JUICE; AREA UNDER THE CURVE; ARTICLE; BUTTER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TOLERABILITY; FAT INTAKE; FOOD DRUG INTERACTION; HUMAN; LIPID DIET; LOW FAT DIET; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MEAL; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE;

ADULT; ANTI-ANXIETY AGENTS; AREA UNDER CURVE; BENZODIAZEPINES; CROSS-OVER STUDIES; DIETARY FATS; FASTING; FOOD-DRUG INTERACTIONS; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 18744387969     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270002042012004     Document Type: Article

References (15)

1. O'Hair DE, Winsauer HJ: Evaluation of short-term treatment with 30 mg of quazepam in insomniac outpatients. Clin Ther 1981;4:291-301.
2. Kales A: Quazepam: Hypnotic efficacy and side effects. Pharmacotherapy 1990;10:1-12.
3. Mendels J: Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. J Clin Psychiatry 1994;55:60-65.
4. Roth TG, Roehrs TA, Koshorek GL, Greenblatt DJ, Rosenthal LD: Hypnotic effects of low doses of quazepam in older insomniacs. J Clin Psychopharmacol 1997;17:401-406.
5. Fleisher D, Li C, Zhou Y, Pao LH, Karim A: Drug, meal and formulation interactions influencing drug absorption after oral administration: Clinical implications. Clin Pharmacokinet 1999;36:233-254.
6. Singh BN: Effects of food on clinical pharmacokinetics. Clin Pharmacokinet 1999;37(3):213-255.
7. Rolan PE, Mercer AJ, Weatherley BC, Holdich T, Meire H, Peck RW, et al: Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 1994;37:13-20.
8. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC: Quantification of sleepiness: A new approach. Psychophysiology 1973;10:431-436.
9. Food and Drug Administration: Guidance for Industry: Food-Effect Bioavailability and Fed Bioequivalence Studies: Study Design, Data Analysis, and Labeling. Bethesda, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2001.
10. Zhi J, Rakhit A, Patel IH: Effects of dietary fat on drug absorption. Clin Pharmacol Ther 1995;58:487-491.
11. Gupta SK, Ellinwood EH Jr: Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam. Pharm Res 1988;5:365-368.
12. Truswell AS: Evaluation of dietary recommendations, goals, and guidelines. Am J Clin Nutr 1987;45:1060-1072.
13. Doose DR, Minn FL, Stellar S, Nayak RK: Effects of meals and meal composition on the bioavailability of fenretinide. J Clin Pharmacol 1992;32:1089-1095.
14. Ankier SI, Goa KL: Quazepam: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia. Drugs 1988;35:42-62.
15. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, et al: Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71:11-20.